Drug intelligence / Profile preview

FA-DOX-Ng

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Intravenous
01

Overview

**FA-DOX-Ng** is an experimental folate receptor-targeted, doxorubicin-loaded chitosan nanogel developed as a pH-responsive nanomedicine for colorectal cancer. Folic-acid surface targeting is intended to enhance folate receptor-mediated uptake by tumor cells, while the chitosan nanogel carrier releases doxorubicin preferentially in acidic tumor-associated conditions. In HT-29 colorectal cancer cells, the formulation increased doxorubicin cytotoxicity and induced apoptosis, with reported modulation of PTEN, AKT, BAX, BCL2, and caspase-associated apoptotic signaling. It is a preclinical delivery formulation rather than an approved pharmaceutical product.

Other names
folate-conjugated doxorubicin-loaded chitosan nanogel
02

Targets

DNAFOLR1 (FRα)TOP2A (DNA topoisomerase II)

Beyond the preview

Go deeper on FA-DOX-Ng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FA-DOX-Ng.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call